CADL financials
Candel Therapeutics (CADL) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
CADL income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$48.27M | -$38.18M | -0.72 |
| 2024 | – | – | -$33.37M | -$55.18M | -1.74 |
| 2023 | – | – | -$38.39M | -$37.94M | -1.31 |
| 2022 | $125.00K | – | -$34.72M | -$18.79M | -0.65 |
| 2021 | $125.00K | – | -$25.73M | -$36.12M | -1.91 |
| 2020 | $125.00K | – | -$13.81M | -$17.68M | -1.52 |